Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study

Table 5 Maintenance sorafenib dose modification table

Dose level 1	Dose level 2	Dose level 3
400 mg b.i.d	400 mg q.d	400 mg q.o.d
200 mg × 2 tablets b.i.d (morning & evening)	200 mg × 2 tablets q.d (morning)	200 mg × 2 tablets q.o.d (morning)

ISSN: 1748-717X